Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.4
Condensed Consolidated Balance Sheets - USD ($)
Dec. 31, 2022
Jun. 30, 2022
Current assets:    
Cash $ 49,008 $ 280,877
Accounts receivable (net of allowance of $0 and $0, respectively) 74,421 93,674
Inventory 453,617 331,531
Other current asset 103,026 137,797
Total current assets 680,072 843,879
Total assets 680,072 843,879
Current liabilities:    
Accounts payable 515,010 234,152
Accrued expense - related party 27,000
Convertible notes payable - net of discounts 2,894,199 344,151
Note payable, net of discount 423,186  
Total current liabilities 3,859,395 578,303
Commitments and contingencies
Stockholders’ equity:    
Series A Preferred Stock, ($0.001 par value, 1,000,000 shares authorized, and 1,000 issued and outstanding as of December 31, 2022 and June 30, 2021, respectively) 1 1
Series B Preferred Stock, ($0.001 par value, 5,000 shares authorized, and 2,450 and 3,260 issued and outstanding as of December 31, 2022 and June 30, 20221, respectively) 2 3
Common stock, ($0.001 par value, 200,000,000 shares authorized, and 99,812,854 issued and outstanding as of December 3, 2022 and 91,814,484 issued and outstanding as of June 30, 2022, respectively) 99,813 91,814
Additional paid in capital 34,285,356 28,275,216
Deferred compensation (16,000)
Accumulated deficit (37,548,495) (28,101,458)
Total Stockholders’ Equity (3,179,323) 265,576
Total Liabilities and Stockholders’ Equity $ 680,072 $ 843,879